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Prolactin. administered exogenously. has been shown to be trophic to the liver. 
causing increases in the liver weight-to-body weight ratiO. in ornithine de-
carboxylase activity, and in thymidine kinase activity. To investigate the effect 
of endogenous hyperprolacl'inemia on hepatic regeneration, pituitary isografts 
were placed beneath the renal capsule in rats 2 weeks before the rats under-
went a two-thirds partial hepatectomy. Prolactin levels 2 weeks after the trans-
plant were greater in the animals with the pituitary isografts compared with 
levels in controls. The increase in the liver weight-to-body weight ratio after 
hepatectomy was similar In the rats with pituitary transplant and the controls. 
However, chronic hyperprolactinemia was associated with increased basal 
levels of ornithine decarboxylase activity and thymidine kinase activity. Both 
ornithine decarboxylase activity and thymidine kinase activity increased after 
partial hepatectomy. and the magnitude of the changes was similar for both 
groups of animals. The levels of estrogen receptor activity before the partial 
hepatectomy and the reduction in receptor activity that follows partial hepa-
tectomy were similar in the two groups of animals. Moreover. the levels of an-
drogen receptor activity within the liver before partial hepatectomy and the 
increase in receptor activity after hepatectomy were similar in the two groups 
of animals. Thus. chronic sustained hyperprolactinemla has no beneficial effect 
on the hepatic regenerative response, despite induction of both basal ornithine 
decarboxylase and thymidine kinase activities. (J LAB CLiN MED 1988;112: 
644-51) 
Abbreviations: ACS = aqueous counting solution; DEAE = diethylaminoethyl; EDTA = ethylene-
diaminetetraacetic acid; Tris = tris-(hydroxymethyl)-aminomethane 
The mammalian liver responds to injury with a hepatic regenerative response that occurs rapidly 
and at a rate that exceeds that experienced by 
most embryonic and malignant tissues. I ,2 The origin 
and nature of the factors that initiate and terminate this 
regenerative response remain unknown. 3 Many studies 
have suggested that the liver may be the source of at 
least one of the factors that initiate hepatic regenera-
tion.4-8 Thus, extracts from the regenerating liver have 
been shown to stimulate liver growth, whereas extracts 
prepared from intact livers either inhibit or have no 
effect on liver growth. 
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Prolactin receptors are known to exist in the liver, 
and transiently increased levels of prolactin have been 
shown to increase the activity of ornithine decarbox-
ylase, a key enzyme in the biosynthesis of polyamines 
present in the liver, which is considered to be the ini-
tiation site for subsequent hepatic regeneration. 9- 13 An 
increase in the hepatic activity of thymidine kinase, the 
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rate-limiting enzyme for DNA synthesis, has been seen 
also in response to a transient prolactin exposure.1 2 In 
several studies, prolactin has been reported to act as a 
trophic factor, causing an increase in the liver weight-
to-body weight ratio and producing a hepatic hyper-
plastic response. 14.15 Moreover, prolactin administration 
to dwarf mutant mice reverses both the growth retar-
dation and the liver atrophy present in such animals. 16 
Recent studies have indicated that the growth-
promoting effects of prolactin, in organs like the pigeon 
crop-sac, involve both direct and indirect actions of 
prolactin. 17 Thus, the growth-promoting effects of pro-
lactin on the liver also may involve both direct and 
indirect effects, inasmuch as extracts prepared from the 
regenerating liver are known to stimulate hepatic 
growth in the absence of prolactin. 4-8 
Prolactin levels are known to be increased in indi-
viduals with cirrhosis, particularly individuals with por-
tal systemic encephalopathy. 18 This endogenous hyper-
prolactinemia is thought to occur on a central basis as 
a result of the accumulation of false neurotransmitters 
that modulate prolactin secretion. This endogenous hy-
perprolactinemia may actually be advantageous to in-
dividuals with cirrhosis and may enhance hepatocellular 
regeneration, thereby maintaining hepatic function de-
spite advanced disease. Therefore, attempts to correct 
the hyperprolactinemia in such cases may be disadvanta-
geous, particularly in cases with far-advanced disease. 
All studies that have examined the effect of prolactin 
on the regenerative response of the liver have involved 
the administration of exogenous hormone to intact an-
imals. In the present study we have investigated the 
effect of endogenous hyperprolactinemia, such as that 
which occurs in cases of advanced disease with portal 
systemic encephalopathy, produced by pituitary iso-
grafts, on the hepatic regenerative response that follows 
a 70% partial hepatectomy in female rats. 
METHODS 
Animals and chemicals. Adult female inbred Wistar rats 
weighing 150 to 250 gm were purchased from Harlan 
Sprague-Dawley, indianapolis, Ind. Carbon 14-labeled or-
nithine (57.6 mCi/mmol), tritiated estradiol (99 Cilml), 
RI881 (87 Ci/mmol). and unlabeled Rl881 were purchased 
from DuPont NEN Medical Products. North Billerica, Mass. 
Tritiated thymidinc (5 mllmmol) and ACS scintillation fluid 
were obtained from Amersham Corp., Arlington Heights, Ill. 
Absolute ethanol and DEAE cellulose paper were purchased 
from U.S. Industrial Chemical Co., Tuscola, Ill., and 
BioRad, Richmond, Calif., respectively. Sigma Chemical Co, 
St. Louis, was the source for the unlabeled ornithine, pyri-
doxal phosphate, Tris base, diethylstilbestrol, adenosine tri-
phosphate, sodium molybdate, nicotinamide adenine dinu-
cleotide, calf thymus DNA, and bovine serum albumin. All 
other chemicals were obtained from Fisher Chemical Co., 
Pittsburgh, Pa. 
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Surgical procedures. The rats were randomly allocated 
to either of two groups, the experimental group or the control 
group. Pituitary transplantation in the experimental rats was 
accomplished via a right loin incision cxposing the right kid-
ney and the insertion under the renal capsule of two pituitary 
glands obtained from two donor animals. The pituitary iso-
grafts were maintained in position by closing the renal capsule 
with 5.0 chromic catgut. The animals in the control group 
underwent an identical sham procedure during which the renal 
capsule was opened and closed with 5.0 chromic catgut with-
out the insertion of two pituitary glands. Two weeks later 
both experimental and control groups of rats underwent a 
standard two-thirds partial hepatectomy as described previ-
ously by Higgins and Anderson. 19 All surgical procedures 
were performed under light ether anesthesia between 9 and 
11 AM to eliminate any effect of diurnal variations on the 
hepatic regenerative response. 
At various times up to 48 hours after partial hepatectomy, 
animals from both the experimental and control groups were 
bled for prolactin levels, anesthetized with ether, weighed, 
and killed. The livers were removed, weighed, and homog-
enized in 4 vol ice-cooled buffer consisting of 0.25 mollL 
sucrose, 1.5 mmollL EDTA, 10 mmollL mercaptoethanol, 
and 10 mmoll L Tris-HCl (pH 7.4) with a Brinkmann Polytron 
homogenizer (Brinkmann Instruments Inc., Westbury, N.Y.). 
Hepatic cytosol was prepared by centrifugation at 103,000 g 
for 1 hour at 4° C. All cytosolic enzyme assays were per-
formed immediately after preparation of the cytosol. 
Prolactin assay. The serum prolactin levels in the animals 
in the study were determined by radioimmunoassay with ma-
terials obtained from the National Hormone and Pituitary 
Program of the National Institutes of Health. All samples were 
assayed in a single assay to eliminate interassay variation. 
The sensitivity of the assay was 0.1 mg rat prolactin per tube. 
The intraassay and interassay coefficients of variation for this 
assay were 10% and 15%, respectively. 
Ornithine decarboxylase activity. Ornithine decarbox-
ylase activity within the liver cytosol was determined by mea-
suring the 14CO, released from labeled ornithine. 20 In brief, 
this assay consisted of the preincubation of 0.4 ml cytosol 
for 5 minutes at 37° C with a mixture containing 0.2 
mmollL pyridoxal phosphate, 5 mmollL dithiothreitol, 
1.5 mm L-ornithine in 10 mmollL Tris-HCl (pH 8.0). There-
after. 0.5 ]..LCi L-14C-D-L-ornithine was added to the mixture, 
and 250 ]..Ll ethanohimine-ethylene glycol (2: 1) was placed 
in the center well to act as a CO2 trap. The assay flask was 
then sealed and incubated at 37° C for I hour. The reaction 
was terminated by the addition of 0.1 ml saturated trichlo-
roacetic acid solution to the reaction mixture. The reaction 
flask was maintained at 37° C for an additional 1 hour, and 
the CO2 trapping solution was then removed and placed into 
a glass scintillation vial containing 10 ml ACS scintillation 
fluid. The radioactivity present in the CO2 trapping solution 
was measured in a liquid scintillation system (Tri-Carb 
460 CD; Packard Instrument Co., Downers Grove, Ill). 
Thymidine kinase activity. Thymidine kinase activity 
within the liver cytosol was determined by measuring the 
in vitro conversion of thymidine to thymidine phosphate." 
The reaction mixture contained 0.1 ml cytosol, 850 ]..Ll in-
cubation buffer consisting of 5 mmollL adenosine triphos-
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Fig. 1. Plasma prolactin levels after partial hepatectomy in rats with pituitary isografts (pituitary transplant plus 
partial hepatectomy) and in control animals (sham transplant plus partial hepatectomy), mean ± SEM. ** 
p < 0.01. *** p < 0.001. 
phate and 3.6 mmollL MgCI, in 50 mmollL Tris-HCI (pH 
8.0), and 50 J..LI of a J..LmollL tritiated thymidine. The reaction 
was maintained at 37° C for 10 minutes and terminated by 
the immersion of the reaction vessel into boiling water for 2 
minutes. After cooling in an ice bath, the denatured protein 
was removed by centrifugation at 1500 g for 5 minutes at 
4° C. A 0.1 ml aliquot of the supernatant was then spotted 
on a 3.8 x 3.8 em piece of DEAE cellulose paper. The paper 
was washed twice with I mmoll L ammonium formate for 5 
minutes followed by distilled water for 3 minutes. Thereafter, 
the paper was placed in a glass scintillation vial, and the 
radioactivity was eluted into solution by the addition of I ml 
of a 0.1 mollL HCI and 0.2 mollL KCI mixture. After 15 
minutes 10 ml ACS scintillation fluid was added to the vial, 
and the amount of radioactivity in the scintillation fluid was 
determined as described above for ornithine decarboxylase. 
Estrogen and androgen receptor assays. The activity 
of the cytosolic estrogen receptors in the liver was determined 
by measuring the specific binding of a saturating concentration 
of tritiated estradiol. 22 To stabilize the estrogen receptor, the 
hepatic cytosol was diluted I: I with buffer consisting of 40 
mmollL sodium molybdate, 1.5 mmollL EDTA, and 10 
mmoll L Tris-HCl (pH 7.4). Total tritiated estradiol binding 
was measured by mixing 200 J..LI of the diluted cytosol with 
25 J..LI of 30 nmollL radioactive steroid and 25 J..Ll ethanol. 
Nonspecific binding was measured in a parallel assay in which 
the ethanol was replaced with 25 J..LI (3 J..Lmol) unlabeled 
diethylstilbestrol dissolved in ethanol. All assays for estrogen 
receptor contained I J..LmollL 2-methoxyestriol to block any 
contribution of a male-specific estrogen binder to total estro-
gen binding. The mixture was incubated for 2 hours at 4° C, 
and the reaction was terminated by the addition of 0.4 ml of 
1 % dextran-coated charcoal to remove any unbound steroid. 22 
The mixture was then centrifuged for 5 minutes at 1500 g at 
4° C, and the supernatant was transferred carefully to a scin-
tillation vial containing 8 ml ACS scintillation fluid. The 
radioactivity present in the mixture was counted as described 
above. 
The assay for cytosolic androgen receptor activity in the 
hepatic cytosol was similar in design to that described above 
for the cytosolic estrogen receptor assay, with the following 
differences.23 Tritiated R 1881, a synthetic androgen, was used 
as the radioactive ligand, and unlabelcd R 1881 was used in 
the assays for nonspecific binding. The binding of RI881 to 
glucocorticoid receptors was blocked by the addition of 5 J..Lm 
triamcinolone acetonide to the androgen receptor assay mix-
ture. The mixture was allowed to incubate overnight at 4° C, 
after which any excess steroid was removed with dextran-
coated charcoal. After centrifugation at 1500 g for 5 minutes 
at 4° C, the resultant supernatant was decanted into a scin-
tillation vial with 8 ml ACS scintillation fluid, and the radio-
activity result in the supernatant was counted as previously 
described for the estrogen receptor assay. 
Miscellaneous methods. The method of Lowry et al.24 
was used to determine the cytosolic protein concentration, 
with bovine serum albumin being used as the standard. 
Statistical methods. All results are presented as mean 
values ± SEM. Statistical analysis of the data was performed 
by using Student's t test. A p value of less than 0.05 was 
used to identify a significant difference. 
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Fig. 2. Changes in liver weight -to-body ratio after partial hepatectomy in animals with pituitary transplant 
(pituitary transplant plus partial hepatectomy) and control animals (sham transplant plus partial hepatectomy), 
mean ± SEM. 
RESULTS 
The serum prolactin levels in the two groups of an-
imals in the study are shown in Fig. 1. An approxi-
mately fourfold increase in prolactin levels above that 
of the controls was seen in the animals with pituitary 
grafts 2 weeks after pituitary transplantation. Prolactin 
levels increased further in the experimental group after 
partial hepatectomy but remained unchanged after par-
tial hepatectomy in the sham-operated controls. 
The rate of hepatic regrowth after a 70% partial hep-
atectomy is presented in Fig. 2. The liver weight-to-
body weight ratio increased approximately twofold be-
tween 6 and 48 hours after partial hepatectomy in both 
groups. No statistical difference in the rate of hepatic 
growth between the two groups of rats was seen at any 
time point. 
The chronic hyperprolactinemia present in the ex-
perimental group compared with the sham-operated 
control group was associated with an increased basal 
level of ornithine decarboxylase activity within the liver 
before partial hepatectomy, as shown in Fig. 3. After 
the 70% partial hepatectomy, a twofold to threefold 
increase in the activity of this enzymatic activity present 
in the hepatic cytosol was observed in both groups of 
animals. The peak activity after partial hepatectomy 
was observed at 6 hours in the control animals and at 
24 hours in the animals with transplants. The ornithine 
decarboxylase activity at 24 hours after partial hepatec-
tomy was similar in both groups of animals in the study. 
The activity of thymidine kinase in the hepatic cy-
tosol of the two groups of animals in the study is shown 
in Fig. 4. As was the case with the ornithine decar-
boxylase activity, the basal activity present in the liver 
before the 70% partial hepatectomy was greater in the 
animals with the pituitary grafts than in the sham-
operated controls (p < 0.05). After partial hepatec-
tomy, a significant increase in thymidine kinase activity 
was seen within the liver in both groups of animals. 
Moreover, the magnitude of the induced change in thy-
midine kinar,e activity was similar for both groups of 
animals. 
As presented in Fig. 5, the hepatic cytosolic estrogen 
receptor activity before the 70% partial hepatectomy 
was similar in the two groups of animals in the study, 
despite a fourfold increase in the basal prolactin level 
in the animals with the pituitary isografts. Partial hep-
atectomy was followed by a marked reduction in the 
cytosolic activity of the estrogen receptor in both 
groups, and as was the case with thymidine kinase, the 
magnitude of the response was similar for both groups 
of animals at each of the time points observed. 
The level of androgen receptor activity was similar 
in the two groups of animals in the study before the 
partial hepatectomy (Fig. 6). A slight decrease in an-
drogen receptor activity was observed initially at 6 
hours, but by 24 hours a minimal increase in androgen 
receptor activity was seen in both groups of animals. 
At 48 hours after partial hepatectomy, the hepatic an-
drogen receptor levels were no different from those 
observed before the hepatic resection. 
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Fig. 3. Ornithine decarboxylase activity (counts per minute per milligram of protein) after partial hepatectomy 
in animals with pituitary transplant (pituitary transplant plus partial hepatectomy) and control animals (sham 
transplant plus partial hepatectomy), mean ± SEM. * p < 0.05. 
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Fig. 4. Thymidine kinase activity (disintegrations per minute per milligram of protein) after partial hepatectomy 
in animals with pituitary transplant (pituitary transplant plus partial hepatectomy) and control animals (sham 
transplant plus partial hepatectomy), mean ± SEM. * P value < 0.05. 
The results of the present study reveal that chronic 
sustained endogenous hyperprolactinemia induced by 
ectopic pituitary isografts does not influence the regen-
erative response observed in rats after partial hepatec-
tomy, as has been reported to occur with the admin-
istration of exogenous prolactin, which produces only 
a transient hyperprolactinemia. Chronic sustained en-
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Fig. 5. Changes in hepatic estrogen receptor level after partial hepatectomy in animals with pituitary transplant 
(pituitary transplant plus partial hepatectomy) and control animals (sham transplant plus partial hepatectomy). 
mean ± SEM. ** p < 0.01. 
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Fig. 6. Changes in hepatic androgen receptor level after partial hepatectomy in animals with pituitary transplant 
(pituitary transplant plus partial hepatectomy) and control animals (sham transplant plus partial hepatectomy). 
mean ± SEM. 
dogenous hyperprolactinemia did not modify the activ-
ity of hepatic estrogen and androgen cytosolic receptors 
seen either before or after a 70% partial hepatectomy. 
Previous studies have suggested that the administra-
tion of exogenous prolactin enhances the hepatic re-
generative response and may even be involved in the 
regulation of this unique hepatic response to injury. 
Specifically, the administration of exogenous prolactin 
has been shown to increase the liver weight-to-body 
weight ratio at various time points after partial hepa-
tectomy and to produce hepatocyte hyperplasia in intact 
rats.14 The administration of prolactin to animals has 
650 Kahn et al. 
been shown also to significantly increase hepatic RNA 
synthesis 16 and to reverse the growth retardation and 
hepatic atrophy present in congenital dwarf mice. 15 Fur-
thermore, the administration of exogenous prolactin has 
been coupled to the induction of activity of hepatic 
ornithine decarboxylase, an enzyme thought to initiate 
and regulate the regenerative response to injury. 1 1-13 
With this background in mind, and recognizing that 
chronic sustained hyperprolactinemia occurs often in 
individuals with cirrhosis, particularly those with ad-
vanced disease with portal systemic encephalopathy, 
it appeared appropriate to investigate the effects of 
chronic sustained hyperprolactinemia on the regenera-
tive response after partial hepatectomy. 
Pituitary isografts, placed remote from the hypo-
thalamus, are well known to be free of hypothalamic 
inhibitory factors that regulate prolactin secretion and 
to produce an excessive sustained secretion of en-
dogenous prolactin. 252R In the present study, pituitary 
grafts, placed under the renal capsule, were used to 
produce a fourfold increase in basal prolactin levels. 
The regenerative response of the liver in response to a 
70% partial hepatectomy was examined in animals with 
and without chronic sustained hyperprolactinemia. 
Ornithine decarboxylase, the rate-limiting enzyme in 
polyamine synthesis (which is thought to play an es-
sential role in proliferating tissues), and thymidine ki-
nase (the enzyme that phosphorylates thymidine before 
it is incorporated into DNA during DNA synthesis) 
were used as biochemical indices of hepatic regener-
ation. 
The results of these studies clearly demonstrate that 
chronic sustained hyperprolactinemia does not influ-
ence the hepatic regenerative response seen after partial 
hepatectomy in the rat. This finding was unexpected, 
because prolactin is known to induce ornithine decar-
boxylase,"-J3 and the level of this enzyme within the 
liver of the animals in the study that had hyperprolac-
tinemia was higher (p < 0.05) (Fig. 3) than it was in 
the control rats that did not have hyperprolactinemia. 
These results wre unexpected also, because the thy-
midine kinase activity present in the liver of the animals 
with the pituitary isografts before partial hepatectomy 
was greater (p < 0.05) (Fig. 4) than that seen in the 
control animals without pituitary isografts. These re-
sults are important in that they suggest that treatment 
of chronic portal systemic encephalopathy directed at 
correcting the endogenous hyperprolactinemia seen in 
this condition probably does not have an untoward ef-
fect on the hepatocellular regenerative response, which 
may be crucial for the maintenance of adequate hepatic 
function. 
Prolactin receptors are well known to be induced by 
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estrogen administration. 29 Moreover, estradiol levels in-
crease after major hepatic resection in humans and 
animals.23 In addition, hyperprolactinemia has been 
shown to induce adrenal androgen production, and both 
estrogens and androgens have been reported to act as 
either inducers or modifiers of the hepatic regenerative 
response to a variety of stimuli. 23 However, despite 
these findings, chronic sustained hyperprolactinemia, 
as produced in these studies, did not affect the hepatic 
regenerative response. 
The liver of the male rat loses many of its male-
specific characteristics during the regeneration that oc-
curs after partial hepatectomy.23 An increase in serum 
estradiol levels and total hepatic estrogen receptor ac-
tivity and a reduction in serum testosterone levels and 
hepatic androgen receptor activity are known to occur 
after partial hepatectomy both in male rats and in hu-
mans, and these may be linked somehow to the ob-
served hepatic regenerative response.2.1 Although the 
total hepatic estrogen receptor level increases after a 
partial hepatectomy, the cytosolic estrogen receptor ac-
tivity is reduced as the estradiol receptor shifts from a 
cytosolic location to the nucleus. It is this transfer of 
the cytosolic estrogen receptor to the hepatic nucleus 
that is thought to play an initiating role in the regulation 
of liver regeneration. 23 
It was anticipated that sustained hyperprolactinemia 
might alter the androgen-estrogen balance of the ani-
mals, both in terms of the two major sex hormones and 
their levels in serum and in terms of their receptor 
activities in sex steroid-responsive tissues, particularly 
the liver, and thereby might affect the rate of hepatic 
growth occurring after a 70% hepatectomy in a positive 
direction. However, the chronic sustained hyperprolac-
tinemia produced in these studies had no effect on the 
activity of hepatic estrogen and androgen receptors, ei-
ther before or after the partial hepatectomy stimulus. 
As a result, the changes in hepatic estrogen and andro-
gen receptor activity observed after partial hepatectomy 
were comparable to those described previously in nor-
mal animals. 23 
In the absence of a change in the activity of hepatic 
cytosolic sex steroid receptors, chronic sustained hy-
perprolactinemia has no beneficial effect on the hepatic 
regenerative response, despite basal inductions of both 
ornithine decarboxylase and thymidine kinase activities 
within the liver, which would have been expected to 
have primed the liver to undergo a regenerative re-
sponse. These data further suggest an important regu-
latory role for sex steroids, and particularly for their 
receptor activities and variation within the hepatocyte. 
on the hepatic regenerative response that follows he-
patic injury. 
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